Marksans Pharma slipped 1.50% to Rs 173.85 after the United States Food and Drug Administration (US FDA) issued 5 observations in Form 483 after inspecting the company’s Goa-based plant.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
